Annual FCF
-$8.62 M
+$13.17 M+60.43%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual free cash flow is -$8.62 million, with the most recent change of +$13.17 million (+60.43%) on September 30, 2024.
- During the last 3 years, SONN annual FCF has risen by +$13.94 million (+61.79%).
- SONN annual FCF is now -287.28% below its all-time high of -$2.23 million, reached on September 30, 2019.
Performance
SONN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.17 M
-$88.60 K-2.88%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly free cash flow is -$3.17 million, with the most recent change of -$88.60 thousand (-2.88%) on September 30, 2024.
- Over the past year, SONN quarterly FCF has dropped by -$88.60 thousand (-2.88%).
- SONN quarterly FCF is now -537.99% below its all-time high of $723.80 thousand, reached on March 31, 2024.
Performance
SONN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.62 M
+$1.56 M+15.32%
September 30, 2024
Summary
- As of February 6, 2025, SONN TTM free cash flow is -$8.62 million, with the most recent change of +$1.56 million (+15.32%) on September 30, 2024.
- Over the past year, SONN TTM FCF has increased by +$1.56 million (+15.32%).
- SONN TTM FCF is now -347.82% below its all-time high of -$1.92 million, reached on March 31, 2020.
Performance
SONN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SONN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.4% | -2.9% | +15.3% |
| 3 y3 years | +61.8% | -2.9% | +15.3% |
| 5 y5 years | -287.3% | -2.9% | +15.3% |
SONN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.8% | -538.0% | +62.3% | at high | +69.8% |
| 5 y | 5-year | -287.3% | +69.8% | -538.0% | +62.3% | -347.8% | +69.8% |
| alltime | all time | -287.3% | +69.8% | -538.0% | +62.3% | -347.8% | +69.8% |
Sonnet BioTherapeutics Holdings Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$8.62 M(-60.4%) | -$3.17 M(+2.9%) | -$8.62 M(-15.3%) |
| Jun 2024 | - | -$3.08 M(-525.8%) | -$10.18 M(-23.4%) |
| Mar 2024 | - | $723.80 K(-123.4%) | -$13.28 M(-30.0%) |
| Dec 2023 | - | -$3.09 M(-34.6%) | -$18.96 M(-13.0%) |
| Sep 2023 | -$21.79 M(-23.8%) | -$4.73 M(-23.5%) | -$21.79 M(-6.3%) |
| Jun 2023 | - | -$6.18 M(+24.8%) | -$23.24 M(-8.7%) |
| Mar 2023 | - | -$4.96 M(-16.2%) | -$25.47 M(-3.1%) |
| Dec 2022 | - | -$5.92 M(-4.4%) | -$26.29 M(-8.0%) |
| Sep 2022 | -$28.58 M | -$6.19 M(-26.4%) | -$28.58 M(+0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.41 M(+45.7%) | -$28.34 M(+10.0%) |
| Mar 2022 | - | -$5.77 M(-29.7%) | -$25.77 M(-0.1%) |
| Dec 2021 | - | -$8.21 M(+38.3%) | -$25.78 M(+14.3%) |
| Sep 2021 | -$22.56 M(+43.8%) | -$5.94 M(+1.6%) | -$22.55 M(+35.7%) |
| Jun 2021 | - | -$5.84 M(+1.0%) | -$16.61 M(+54.3%) |
| Mar 2021 | - | -$5.79 M(+16.2%) | -$10.77 M(+55.9%) |
| Dec 2020 | - | -$4.98 M(+158.8%) | -$6.91 M(+258.8%) |
| Sep 2020 | -$15.69 M(+605.0%) | - | - |
| Mar 2020 | - | -$1.92 M | -$1.92 M |
| Sep 2019 | -$2.23 M | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual free cash flow?
- What is the all time high annual FCF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual FCF year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly free cash flow?
- What is the all time high quarterly FCF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly FCF year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM free cash flow?
- What is the all time high TTM FCF for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM FCF year-on-year change?
What is Sonnet BioTherapeutics Holdings annual free cash flow?
The current annual FCF of SONN is -$8.62 M
What is the all time high annual FCF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual free cash flow is -$2.23 M
What is Sonnet BioTherapeutics Holdings annual FCF year-on-year change?
Over the past year, SONN annual free cash flow has changed by +$13.17 M (+60.43%)
What is Sonnet BioTherapeutics Holdings quarterly free cash flow?
The current quarterly FCF of SONN is -$3.17 M
What is the all time high quarterly FCF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly free cash flow is $723.80 K
What is Sonnet BioTherapeutics Holdings quarterly FCF year-on-year change?
Over the past year, SONN quarterly free cash flow has changed by -$88.60 K (-2.88%)
What is Sonnet BioTherapeutics Holdings TTM free cash flow?
The current TTM FCF of SONN is -$8.62 M
What is the all time high TTM FCF for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM free cash flow is -$1.92 M
What is Sonnet BioTherapeutics Holdings TTM FCF year-on-year change?
Over the past year, SONN TTM free cash flow has changed by +$1.56 M (+15.32%)